SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
analysts and calls -- ML
An SI Board Since September 2002
Posts SubjectMarks Bans
238 19 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
138BIIB Biogen IDEC Inc. (BIIB, $35.84, C-2-9) Maintain Neutral. Q1 Results: Lowertom pope-4/28/2005
137AMGN Amgen Inc (AMGN, $59.25, C-1-9) Reiterate Buy and $77 PT. Q1 Results: Raistom pope-4/22/2005
136<<Eyetech Pharmaceuticals - Reiterate Buy and $71 PT>> Right on marMiljenko Zuanic-4/21/2005
135EYET: Eyetech Pharmaceuticals Inc. (EYET, $29.01, C-1-9) Eyetech Pharmaceuticaltom pope-4/21/2005
134AMGN: Amgen Inc  Update; Management Could Tighten ’05E EPS To High End of Rangtom pope-4/20/2005
133GILD: Gilead Sciences Inc  Update and Earnings Analysis; Truvada & Tamiflutom pope-4/20/2005
132KOSP Price Target Change Kos Pharmaceuticals Inc (KOSP, $50.46, C-1-9) Reiterattom pope-4/15/2005
131Pfizer Inc (PFE, $26.60, B-2-7) Reiterate Neutral. Bextra’s withdrawal, cut EPS tom pope-4/11/2005
130SEPR Sepracor Inc. (SEPR, $56.52, C-1-9) Maintain Buy and $73 PT. Lunesta has btom pope-4/6/2005
129CELG Celgene Corporation (CELG, $32.93, C-1-9) Reiterate Buy. Raising PT from $tom pope-3/29/2005
128Ende has stuck with his love of EYET through the down draft, is now getting sometom pope-3/23/2005
127DNA: Price Target Change Genentech Inc (DNA,$60,B-1-9) Reiterate Buy. Raising Ptom pope-3/15/2005
126NPSP: NPS Pharmaceuticals Inc.  Price Target Change; Changing Model To Reflecttom pope-2/4/2005
125WAT Waters Corporation Buy – Raising PO from $48 to $54. Raising our 2005/2006 tom pope-1/28/2005
124CHIR - not too surprising in the light of the earnings: Chiron Corp Sell – Disatom pope-1/27/2005
123This is over a week old (1/10). If any one is interested in any of the fuller ctom pope-1/23/2005
122Pharmas: David Risinger, Merrill Lynch Senior U.S. Pharmaceuticals Analyst, saitom pope-1/21/2005
121Glaxo: GlaxoSmithKline  Sector Review; Pipeline Pipeline Pipeline GSK remains tom pope-1/18/2005
120Ende continues his love affair with injections into the eye: Eyetech Pharmaceuttom pope-1/18/2005
119SEPR Sepracor Inc.  Company Update; Revising Model, Raising Target to $73 We atom pope-1/12/2005
118DNA <i> Update; Avastin Misses Estimates, But We Remain Confident in Itstom pope-1/11/2005
117CELG: Celgene Corporation  Company Update; Pre-Announces In-Line 4Q EPS of $0.tom pope-1/11/2005
116MOGN <i>MGI Pharma Downgrade from Buy to Neutral - Shift from Doc's otom pope-1/11/2005
115Ende on EYET. His top pick in biotech, it seems: <i>Eyetech Pharmaceutictom pope-12/14/2004
114Not biotech, but relevant to some of the things that have been discussed on thestom pope-12/6/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News